Background illustration for clinical trials search

M.D. Anderson Clinical Trials

Find clinical trials for M.D. Anderson. Search for M.D. Anderson clinical trials in different cities and states across the United States.

Filter

Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules

for
Thyroid Nodules, Pulsed Field Ablation
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07226804

Recruiting

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

for
Active Surveillance, Clear Cell Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07023432

Phase 2, Recruiting

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

for
Clinical Stage 0 Cutaneous Melanoma AJCC v8,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT03819296

Phase 1, Recruiting

A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease

for
AML
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 65 - 70+

Code: NCT06973668

Phase 2, Recruiting

Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery

for
Neoadjuvant Treatment, Thyroid Cancer
Location: Charlottesville VA, Cleveland OH, Ann Arbor MI,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06959511

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC

for
Prostate Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06826768

Phase 1, Recruiting

Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05904782

Recruiting

Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

for
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 70

Code: NCT04708054

Phase 2, Phase 3, Recruiting

Baseline Anxiety Trajectories in Pediatric Radiation Therapy Observational Cohort

for
Anxiety, Radiation
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 2 - 12

Code: NCT07575815

Recruiting

Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)

for
Adenoid Cystic Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07162480

Phase 2, Recruiting

Communicating Health Options to Inform Care and Empower Strategic Care Planning (CHOICES): A Multi-layer Randomized Case Vignette Study.

for
Health Options, Strategic Care Planning
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06722846

Recruiting

Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention

for
Liver Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07010315

Recruiting

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

for
Low Risk, Papillary Thyroid Cancer, Radiofrequency Ablation
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07140757

Recruiting

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

for
Phase 2 Study, BMS-986504, MTAP-deleted Pancreatic Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07283705

Phase 2, Recruiting

The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support

for
Neuroendocrine Cervical Cancer, Patient Support
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07532954

Recruiting

Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment

for
Colorectal Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06617858

Phase 2, Recruiting

Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study

for
Phase 2 Study, MCL, BTKi, Rituximab, Glofitamab
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07257055

Phase 2, Recruiting

Phase 2 Study Assessing the Clinical Activity and Safety of Obecabtagene Autoleucel as a Consolidation in Patients With Newly Diagnosed High-risk B-cell Acute Lymphocytic Leukemia (ALL)

for
Acute Lymphocytic Leukemia (ALL)
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07053059

Phase 2, Recruiting

Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

for
Lung Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT02596490

Recruiting

A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases

for
Brain Metastases, Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05048212

Phase 2, Recruiting